← Leaderboards
Dennis S Charney
Emory University
$11,929,023
Attributed
$11,929,023
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $10M · FY2005–10$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$31,988,560 · 13
By mechanism
M01$20,325,852 · 10
C06$9,989,340 · 1
U19$1,245,881 · 1
U01$427,487 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Greg J Siegle$14,069,094
- Michael Davis$14,852,655
- John N Aarsvold$170,655
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectResearch PersonnelGrantResponseClinical ResearchFundingUnited States National Institutes Of HealthDrug Screening /EvaluationHuman Therapy EvaluationInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseSourceReceptorPatient Oriented ResearchResourcesPlacebo ControlMental Disorder ChemotherapyPositron Emission TomographyClinical TrialsPharmaceutical PreparationsSelective Serotonin Reuptake InhibitorPlacebosMagnetic Resonance ImagingFunctional Disorder
Grant awards (30)
Improving Annenberg 23 in Support of Translational Research$9,989,340
C06 · FY2010 · RR · contact PI
General Clinical Research Center$1,482,405
M01 · FY2009 · RR · contact PI
EVALUATION OF THE EFFICACY OF THE NK1 ANTAGONIST GR205171 IN PTSD$20,797
M01 · FY2009 · RR · contact PI
CONTINUOUS INTRAVENOUS KETAMINE IN MAJOR DEPRESSIVE DISORDER$10,521
M01 · FY2009 · RR · contact PI
General Clinical Research Center$4,649,345
M01 · FY2008 · RR · contact PI
EVALUATION OF THE EFFICACY OF THE NK1 ANTAGONIST GR205171 IN PTSD$57,072
M01 · FY2008 · RR · contact PI
CONTINUOUS INTRAVENOUS KETAMINE IN MAJOR DEPRESSIVE DISORDER$26,825
M01 · FY2008 · RR · contact PI
RANDOMIZED,PLACEBO-CONTROLLED TRIAL OF AN AMPAKINE IN MAJOR DEPRESSIVE DISORDER$1,142
M01 · FY2008 · RR · contact PI
General Clinical Research Center$4,606,051
M01 · FY2007 · RR · contact PI
Clinical Assessment of Novel Anti-Depressant-Anxiolytics$313,945
U19 · FY2007 · MH · contact PI
EVALUATION OF THE EFFICACY OF THE NK1 ANTAGONIST GR205171 IN PTSD$101,514
M01 · FY2007 · RR · contact PI
RANDOMIZED,PLACEBO-CONTROLLED TRIAL OF AN AMPAKINE IN MAJOR DEPRESSIVE DISORDER$23,099
M01 · FY2007 · RR · contact PI
THE ALPHA 2C ADRENORECEPTOR IN POST-TRAUMATIC STRESS DISORDER$1,216
M01 · FY2007 · RR · contact PI
General Clinical Research Center$4,605,452
M01 · FY2006 · RR · contact PI
Randomized, placebo-controlled trial/AMPAkine depression$427,487
U01 · FY2006 · MH · contact PI
Clinical Assessment of Novel Anti-Depressant-Anxiolytics$222,029
U19 · FY2006 · MH · contact PI
EVALUATION OF THE EFFICACY OF THE NK1 ANTAGONIST GR205171 IN PTSD$24,129
M01 · FY2006 · RR · contact PI
GENERAL CLINICAL RESEARCH CENTER$4,716,284
M01 · FY2005 · RR
Clinical Assessment of Novel Anti-Depressant-Anxiolytics$227,701
U19 · FY2005 · MH
Clinical Assessment of Novel Anti-Depressant-Anxiolytics$265,708
U19 · FY2004 · MH
Clinical Assessment of Novel Anti-Depressant-Anxiolytics$216,498
U19 · FY2003 · MH
Antiglucocorticoid Therapy in Bipolar Depression$0
Z01 · FY2003 · MH
Soy Isoflavones for the Treatment of Major Depression$0
Z01 · FY2003 · MH
Hydrocortisone Induced changes in Glucose Metabolism$0
Z01 · FY2003 · MH
Tryptophan Depletion in Remitted Depressed Patients$0
Z01 · FY2003 · MH
Glucocorticoid and Mineralocorticoid receptor function$0
Z01 · FY2003 · MH
a2-Adrenoreceptor (AR) Subtype Polymorphisms$0
Z01 · FY2003 · MH
Efficacy of Clozapine for Treatment-Resistant Mania$0
Z01 · FY2003 · MH
Felbamate for Treatment-Resistant Bipolar Depression$0
Z01 · FY2003 · MH
Efficacy of Memantine for Major Depression$0
Z01 · FY2003 · MH